|
Volumn 4, Issue 3, 2002, Pages 176-177
|
Experience of hormonal therapy with anastrozole for previously treated metastatic breast cancer
a a a a |
Author keywords
Anastrozole; Aromatase inhibitors; Hormonal therapy; Metastatic breast cancer
|
Indexed keywords
DISEASES;
HORMONES;
PATIENT TREATMENT;
TOXICITY;
TUMORS;
HORMONAL THERAPY;
BIOMEDICAL ENGINEERING;
ANASTROZOLE;
ANTINEOPLASTIC AGENT;
AROMATASE INHIBITOR;
ESTROGEN RECEPTOR;
HORMONE;
TAMOXIFEN;
ADULT;
AGED;
ARTICLE;
BODY WEIGHT DISORDER;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER GROWTH;
CANCER HORMONE THERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG USE;
EVALUATION AND FOLLOW UP;
FATIGUE;
HUMAN;
ISRAEL;
METASTASIS;
PRIMARY HEALTH CARE;
RETROSPECTIVE STUDY;
STATISTICAL ANALYSIS;
TOXICITY;
TREATMENT OUTCOME;
WEIGHT GAIN;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NITRILES;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TRIAZOLES;
|
EID: 0036281649
PISSN: 15651088
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (8)
|